These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 36525790)

  • 1. The landscape of CRISPR/Cas9 for inborn errors of metabolism.
    Leal AF; Fnu N; Benincore-Flórez E; Herreño-Pachón AM; Echeverri-Peña OY; Alméciga-Díaz CJ; Tomatsu S
    Mol Genet Metab; 2023 Jan; 138(1):106968. PubMed ID: 36525790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas gene therapy.
    Zhang B
    J Cell Physiol; 2021 Apr; 236(4):2459-2481. PubMed ID: 32959897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases.
    Sharma G; Sharma AR; Bhattacharya M; Lee SS; Chakraborty C
    Mol Ther; 2021 Feb; 29(2):571-586. PubMed ID: 33238136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulating CRISPR/Cas9 genome-editing activity by small molecules.
    Chen S; Chen D; Liu B; Haisma HJ
    Drug Discov Today; 2022 Apr; 27(4):951-966. PubMed ID: 34823004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clustered Regularly Interspaced Short Palindromic Repeats and Clustered Regularly Interspaced Short Palindromic Repeats-Associated Protein 9 System: Factors Affecting Precision Gene Editing Efficiency and Optimization Strategies.
    Li J; Tang C; Liang G; Tian H; Lai G; Wu Y; Liu S; Zhang W; Liu S; Shao H
    Hum Gene Ther; 2023 Dec; 34(23-24):1190-1203. PubMed ID: 37642232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in therapeutic application of CRISPR-Cas9.
    Sun J; Wang J; Zheng D; Hu X
    Brief Funct Genomics; 2020 May; 19(3):164-174. PubMed ID: 31769791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 for Human Genome Engineering and Disease Research.
    Xiong X; Chen M; Lim WA; Zhao D; Qi LS
    Annu Rev Genomics Hum Genet; 2016 Aug; 17():131-54. PubMed ID: 27216776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harnessing CRISPR/Cas9 technology in cardiovascular disease.
    Rezaei H; Khadempar S; Farahani N; Hosseingholi EZ; Hayat SMG; Sathyapalan T; Sahebkar AH
    Trends Cardiovasc Med; 2020 Feb; 30(2):93-101. PubMed ID: 30935726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9 Landscape: Current State and Future Perspectives.
    Tyumentseva M; Tyumentsev A; Akimkin V
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of CRISPR-Cas9 Genome Editing Methods in Atherosclerotic Cardiovascular Diseases.
    Sheikh Beig Goharrizi MA; Ghodsi S; Memarjafari MR
    Curr Probl Cardiol; 2023 May; 48(5):101603. PubMed ID: 36682390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 in plants: at play in the genome and at work for crop improvement.
    Hussain B; Lucas SJ; Budak H
    Brief Funct Genomics; 2018 Sep; 17(5):319-328. PubMed ID: 29912293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9 Genome Editing Approaches for Psychiatric Research.
    Gutiérrez-Rodríguez A; Cruz-Fuentes CS; Genis-Mendoza AD; Nicolini H
    Braz J Psychiatry; 2023 May; 45(2):137-145. PubMed ID: 36753615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
    Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
    Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Genome Editing and In Vivo Delivery.
    Ramirez-Phillips AC; Liu D
    AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy.
    Ding S; Liu J; Han X; Tang M
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating genomic insights into cardiovascular medicine: Opportunities and challenges of CRISPR-Cas9.
    Zhang Y; Karakikes I
    Trends Cardiovasc Med; 2021 Aug; 31(6):341-348. PubMed ID: 32603681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.